Dr. Sy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UC, Irvine CA Coll of Med
Irvine, CA 92602- Is this information wrong?
Summary
- Dr. Michael Sy is a neurologist in Irvine, CA and is an Assistant Professor with UC Irvine Health. He received his MD and PhD from University of California Irvine School of Medicine and has been in practice 6 years. He specializes and has experience in neuroimmunology/multiple sclerosis.
Education & Training
University of California (Irvine)Residency, Neurology, 2011 - 2014
University of California, Irvine, School of MedicineClass of 2011
Yale UniversityBS, 2002- University of California (Irvine)Fellowship, Neuroimmunology & Multiple Sclerosis
Certifications & Licensure
CA State Medical License 2013 - 2024- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Marilyn Hilton Innovator Award Hilton Foundation, 2017-2020
Clinical Trials
- A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) Start of enrollment: 2021 Mar 17
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) Start of enrollment: 2020 Dec 03
- Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2017 Mar 24
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAutologous hematopoietic stem cell transplantation for a patient with multiple autoimmune diseases.Pongthep Vittayawacharin, Michael Y Sy, Sanaz Attaripour Isfahani, William E Karnes, Piyanuch Kongtim, Stefan O Ciurea> ;American Journal of Hematology. 2023 Oct 1
- 3 citationsN-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial.Michael Sy, Barbara L Newton, Judy Pawling, Ken L Hayama, Andres Cordon, Zhaoxia Yu, Jens Kuhle, James W Dennis, Alexander U Brandt, Michael Demetriou> ;Journal of Neuroinflammation. 2023 Sep 13
- Case report: Approaches to treatment-refractory and super-refractory glutamic acid decarboxylase antibody-spectrum disorders.Ravi Rajmohan, Shivali Baveja, Dai Nguyen, Eshita Shah, Michael Sy, Sanaz Attaripour, David Swope> ;Frontiers in Immunology. 2023 Jan 1
- Join now to see all
Press Mentions
Depression, Constipation, and Urinary Tract Infections May Precede MS DiagnosisDecember 5th, 2023
Octave Bioscience Gaining Traction Among CliniciansNovember 6th, 2023
Shifting Toward Precision Care in MS Using Disease Activity Tests and Serum BiomarkersOctober 24th, 2023- Join now to see all
Hospital Affiliations
UCI HealthOrange, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
